Hooper R G, Kearl R A
Heart Lung Center, St. Lukes Medical Center, Phoenix.
Chest. 1990 Jan;97(1):138-43. doi: 10.1378/chest.97.1.138.
Short treatment courses of ACS have been shown to be of no demonstrable value in the treatment of ARDS. We gave two patients with persistant ARDS a trial of ACS after they demonstrated pulmonary uptake of 67Ga. Brief initial improvement disappeared with tapering of the ACS. A sustained course of ACS led to resolution of the ARDS in both patients. In all, ten patients with established ARDS were treated with sustained ACS over an 18-month period. The eight additional patients had uninterrupted courses of therapeutic ACS for greater than 21 days. The patients averaged 12 days of greater than 40 mg a day. At the time of treatment, all patients had established ARDS, meeting for at least 72 hours, criteria for the diagnosis of ARDS. A sustained course of ACS may be effective in the treatment of selected patients with established ARDS. Controlled studies of established ARDS are indicated to define the characteristics of these patients and their management.
短期急性冠状动脉综合征(ACS)治疗方案在急性呼吸窘迫综合征(ARDS)治疗中未显示出明显价值。两名持续性ARDS患者在肺部摄取67Ga后接受了ACS试验。ACS初始短暂改善随着剂量减少而消失。持续的ACS疗程使两名患者的ARDS均得到缓解。在18个月期间,共有10例确诊ARDS患者接受了持续ACS治疗。另外8例患者接受了超过21天的不间断治疗性ACS疗程。患者平均每天服用超过40毫克,持续12天。治疗时,所有患者均已确诊ARDS,符合ARDS诊断标准至少72小时。持续的ACS疗程可能对部分确诊ARDS患者有效。需要对确诊ARDS进行对照研究,以明确这些患者的特征及其治疗方法。